Cutler Group’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-3,515
Closed -$6K – 5776
2022
Q2
$6K Sell
3,515
-2,899
-45% -$7.04K ﹤0.01% 3651
2022
Q1
$22K Sell
6,414
-21,858
-77% -$107K ﹤0.01% 2991
2021
Q4
$243K Buy
28,272
+26,872
+1,919% +$171K 0.01% 1172
2021
Q3
$10K Buy
+1,400
New +$11.8K ﹤0.01% 3973

Other funds holding LHDX

Cutler Group's LHDX Position: Q3 2022 in Review

Cutler Group sold out of Lucira Health, Inc. Common Stock (LHDX) in Q3 2022, closing a stake of 3,515 shares — an estimated $6K sold.

Cutler Group first reported a position in LHDX in Q3 2021 and held it in 4 quarters. The position peaked at $243K in Q4 2021. 28 funds tracked by Wall St. Rank hold LHDX as of Q3 2022.

  • Cutler Group reported no remaining Lucira Health, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Cutler Group sold 3,515 Lucira Health, Inc. Common Stock shares in Q3 2022, an estimated $6K.
  • Cutler Group first reported a position in Lucira Health, Inc. Common Stock in Q3 2021 and held it in 4 quarters.
  • Cutler Group's Lucira Health, Inc. Common Stock position peaked at $243K in Q4 2021.
  • 28 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q3 2022.

Based on Cutler Group's 13F filing for Q3 2022, filed 25 Oct 2022.